Meag Munich Ergo’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
38,000
-42,055
| -53% | -$17.6M | 0.43% | 61 |
|
|
2025
Q1 | $39.8M | Buy |
80,055
+28,474
| +55% | +$15.4M | 1.17% | 41 |
|
|
2024
Q4 | $26.8M | Sell |
51,581
-14
| -0% | -$7.7K | 0.85% | 52 |
|
|
2024
Q3 | $31.9M | Buy |
51,595
+969
| +2% | +$574K | 1% | 46 |
|
|
2024
Q2 | $28M | Buy |
50,626
+26,576
| +111% | +$15.2M | 0.93% | 49 |
|
|
2024
Q1 | $14M | Sell |
24,050
-568
| -2% | -$319K | 0.51% | 55 |
|
|
2023
Q4 | $13.1M | Buy |
24,618
+88
| +0.4% | +$42.6K | 0.5% | 60 |
|
|
2023
Q3 | $12.4M | Buy |
24,530
+47
| +0.2% | +$25K | 0.54% | 60 |
|
|
2023
Q2 | $12.8M | Sell |
24,483
-347
| -1% | -$187K | 0.56% | 60 |
|
|
2023
Q1 | $14.3M | Buy |
24,830
+7,883
| +47% | +$4.44M | 0.68% | 53 |
|
|
2022
Q4 | $9.33M | Buy |
16,947
+17
| +0.1% | +$9.01K | 0.5% | 48 |
|
|
2022
Q3 | $8.59M | Sell |
16,930
-1,699
| -9% | -$951K | 0.52% | 44 |
|
|
2022
Q2 | $10.1M | Buy |
18,629
+15,169
| +438% | +$8.35M | 0.6% | 37 |
|
|
2022
Q1 | $2.07M | Buy |
3,460
+3,060
| +765% | +$1.76M | 0.15% | 96 |
|
|
2021
Q4 | $267K | Hold |
400
| – | – | 0.02% | 167 |
|
|
2021
Q3 | $229K | Sell |
400
-10,472
| -96% | -$5.75M | 0.04% | 185 |
|
|
2021
Q2 | $5.49M | Buy |
+10,872
| New | +$5.13M | 0.53% | 67 |
|
|
2021
Q1 | – | Sell |
-2,500
| Closed | -$1.15M | – | 323 |
|
|
2020
Q4 | $1.15M | Hold |
2,500
| – | – | 0.27% | 111 |
|
|
2020
Q3 | $1.1M | Hold |
2,500
| – | – | 0.2% | 115 |
|
|
2020
Q2 | $906K | Buy |
2,500
+1,230
| +97% | +$412K | 0.17% | 125 |
|
|
2020
Q1 | $360K | Sell |
1,270
-6,178
| -83% | -$1.95M | 0.09% | 137 |
|
|
2019
Q4 | $2.42M | Sell |
7,448
-20,591
| -73% | -$6.24M | 0.26% | 98 |
|
|
2019
Q3 | $8.03M | Buy |
28,039
+11,351
| +68% | +$3.25M | 0.41% | 62 |
|
|
2019
Q2 | $4.91M | Hold |
16,688
| – | – | 0.38% | 63 |
|
|
2019
Q1 | $4.51M | Buy |
16,688
+15,418
| +1,214% | +$3.84M | 0.37% | 69 |
|
|
2018
Q4 | $282K | Sell |
1,270
-26,392
| -95% | -$6.19M | 0.03% | 309 |
|
|
2018
Q3 | $6.72M | Buy |
27,662
+6,529
| +31% | +$1.5M | 0.4% | 74 |
|
|
2018
Q2 | $4.38M | Sell |
21,133
-37,268
| -64% | -$7.91M | 0.27% | 123 |
|
|
2018
Q1 | $12M | Sell |
58,401
-1,266
| -2% | -$266K | 0.49% | 51 |
|
|
2017
Q4 | $11.5M | Buy |
59,667
+43,473
| +268% | +$8.33M | 0.44% | 61 |
|
|
2017
Q3 | $3.03M | Buy |
+16,194
| New | +$2.93M | 0.12% | 180 |
|
|
2017
Q1 | – | Sell |
-123,385
| Closed | -$17.6M | – | 355 |
|
|
2016
Q4 | $17.6M | Buy |
+123,385
| New | +$18.2M | 0.82% | 31 |
|
Other funds holding TMO
Meag Munich Ergo's TMO Position: Q2 2025 in Review
Meag Munich Ergo reduced its Thermo Fisher Scientific (TMO) stake by 53% in Q2 2025, selling an estimated $17.6M and leaving 38,000 shares worth $15.4M. The position accounts for 0.43% of the portfolio, ranked #61.
Meag Munich Ergo first reported a position in TMO in Q4 2016 and has held it in 32 quarters since. The position peaked at $39.8M in Q1 2025. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Meag Munich Ergo held 38,000 shares of Thermo Fisher Scientific worth $15.4M as of Q2 2025.
- Meag Munich Ergo sold 42,055 Thermo Fisher Scientific shares in Q2 2025, an estimated $17.6M.
- Thermo Fisher Scientific made up 0.43% of Meag Munich Ergo's portfolio in Q2 2025, its #61 holding.
- Meag Munich Ergo first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 32 quarters since.
- Meag Munich Ergo's Thermo Fisher Scientific position peaked at $39.8M in Q1 2025.
- 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.